Every data-stealing virus requires a unique approach, but these are the essential first steps for reclaiming an infected ...

Concord-Carlisle High School students designed and built hydraulic robotic arms, showcasing their engineering skills.

Last month Perplexity announced the confusingly named “Computer,” its cloud-based agent tool for completing tasks using a harness that makes use of multiple different AI models. This week, the company ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Personal Computer is designed to be your personal assistant with access to all your tools It's ...

Maharashtra's CET Cell has introduced strict new regulations to combat exam malpractice MUMBAI: The use of AI tools, hidden cameras, screen mirroring, smartwatches or any remote-access software during ...

The CSL Ltd (ASX: CSL) share price is 2% higher at $145.71 a piece in Thursday morning trade. At the time of writing, the beaten-down biotech stock is down 15.24% year to date and 44.85% over the year ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...

CSL granted Eli Lilly certain rights for clazakizumab CSl to receive upfront payment of $100 million CSL shares up 2.1% CSL will retain exclusive rights to develop and commercialise clazakizumab for ...

CSL announced the exit of Paul McKenzie as chief executive. Senior executive Gordon Naylor appointed interim CEO. Shares of Australian biotech firm CSL plunged to an 8-year low Wednesday after it ...

SYDNEY, Feb 11 (Reuters) - CSL Ltd (CSL.AX), opens new tab on Wednesday reported an 81% drop in first‑half profit, knocked by weaker blood plasma product and vaccine sales and one-off charges, a day ...

With pressure piling on for CSL, the Australian vaccine and plasma specialist has elected to part ways with its CEO on the eve of its latest earnings announcement. Paul McKenzie, Ph.D., who’s served ...